American Shared Hospital Services (AMS)
- Previous Close
2.9100 - Open
3.0200 - Bid 2.8900 x 1000
- Ask 3.0000 x 2900
- Day's Range
2.9550 - 3.0000 - 52 Week Range
2.1600 - 3.0200 - Volume
6,357 - Avg. Volume
10,066 - Market Cap (intraday)
18.925M - Beta (5Y Monthly) 0.68
- PE Ratio (TTM)
29.90 - EPS (TTM)
0.1000 - Earnings Date May 10, 2024 - May 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 28, 2007
- 1y Target Est
4.80
American Shared Hospital Services provides radiosurgery and radiation therapy equipment to health care providers. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.
ashs.com31
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AMS
Performance Overview: AMS
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AMS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AMS
Valuation Measures
Market Cap
18.42M
Enterprise Value
22.37M
Trailing P/E
29.10
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.87
Price/Book (mrq)
0.81
Enterprise Value/Revenue
1.05
Enterprise Value/EBITDA
3.21
Financial Highlights
Profitability and Income Statement
Profit Margin
2.86%
Return on Assets (ttm)
3.15%
Return on Equity (ttm)
1.02%
Revenue (ttm)
21.32M
Net Income Avi to Common (ttm)
610k
Diluted EPS (ttm)
0.1000
Balance Sheet and Cash Flow
Total Cash (mrq)
13.69M
Total Debt/Equity (mrq)
59.68%
Levered Free Cash Flow (ttm)
2.22M
Research Analysis: AMS
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell